Nanoprecise Sci Corp | $38,000,000 | (Mar 28, 2025)
Mendel | $35,000,000 | (Mar 28, 2025)
Galatea Bio Inc. | $25,000,000 | (Mar 28, 2025)
Certified by Founder
Lodge
Odyssey Therapeutics
start up
United States
- Boston, Massachusetts
- 06/12/2023
- Series C
- $101,000,000
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
- Industry Biotechnology Research
- Website https://www.odysseytx.com/
- LinkedIn https://www.linkedin.com/company/odyssey-tx/about/
MemryX Inc. | $44,000,000 | (Mar 28, 2025)
Mila Beauté | $2,160,000 | (Mar 28, 2025)
Lucky Beverage Co. | $14,200,000 | (Mar 28, 2025)
Taxo (YC S24) | $5,000,000 | (Mar 28, 2025)
BuildVision | $10,000,000 | (Mar 28, 2025)
Yutori | $15,000,000 | (Mar 28, 2025)
Nexthop AI | $110,000,000 | (Mar 27, 2025)
Topanga.io | $8,000,000 | (Mar 27, 2025)
Silna | $27,000,000 | (Mar 27, 2025)